Bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF or B/F/TAF), sold under the brand name Biktarvy, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS and as post-exposure prophylaxis (PEP) to prevent HIV infection following potential exposure.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.